SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005047
Filing Date
2019-05-15
Accepted
2019-05-15 08:21:33
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ruby-20190331x10q.htm 10-Q 2237882
2 EX-31.1 ruby-20190331ex311aae63f.htm EX-31.1 12598
3 EX-31.2 ruby-20190331ex312a06079.htm EX-31.2 12591
4 EX-32.1 ruby-20190331ex32187ce92.htm EX-32.1 8099
5 EX-32.2 ruby-20190331ex322e19727.htm EX-32.2 8085
  Complete submission text file 0001558370-19-005047.txt   7605374

Data Files

Seq Description Document Type Size
6 EX-101.INS ruby-20190331.xml EX-101.INS 1586500
7 EX-101.SCH ruby-20190331.xsd EX-101.SCH 47705
8 EX-101.CAL ruby-20190331_cal.xml EX-101.CAL 52220
9 EX-101.DEF ruby-20190331_def.xml EX-101.DEF 182867
10 EX-101.LAB ruby-20190331_lab.xml EX-101.LAB 460442
11 EX-101.PRE ruby-20190331_pre.xml EX-101.PRE 345966
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38586 | Film No.: 19825188
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1